Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥446.51 Million ≈ $65.34 Million USD) by net assets (CN¥10.70 Billion ≈ $1.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shijiazhuang Yiling Pharmaceutical Co Lt (002603) market capitalisation for the company's overall valuation and market capitalisation.
Shijiazhuang Yiling Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Shijiazhuang Yiling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shijiazhuang Yiling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shijiazhuang Yiling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 002603 cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arcadis N.V.
AS:ARCAD
|
-0.096x |
|
Planet Fitness Inc
NYSE:PLNT
|
-0.315x |
|
Bethel Automotive Safety Systems Co Ltd Class A
SHG:603596
|
-0.008x |
|
Hiwin Technologies Corp
TW:2049
|
0.050x |
|
Hangzhou Hangyang Co Ltd
SHE:002430
|
0.066x |
|
Guangzhou Haige Communications Group Incorporated Co
SHE:002465
|
-0.019x |
|
Siegfried Holding Ltd
SW:SFZN
|
0.143x |
|
Genworth Financial Inc
NYSE:GNW
|
0.015x |
Annual Cash Flow Conversion Efficiency for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. View current stock price of Shijiazhuang Yiling Pharmaceutical Co Lt for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥10.98 Billion ≈ $1.61 Billion |
CN¥1.78 Billion ≈ $259.96 Million |
0.162x | +170.10% |
| 2024-12-31 | CN¥10.20 Billion ≈ $1.49 Billion |
CN¥611.01 Million ≈ $89.41 Million |
0.060x | +340.66% |
| 2023-12-31 | CN¥11.44 Billion ≈ $1.67 Billion |
CN¥155.46 Million ≈ $22.75 Million |
0.014x | -95.74% |
| 2022-12-31 | CN¥10.93 Billion ≈ $1.60 Billion |
CN¥3.49 Billion ≈ $510.37 Million |
0.319x | +447.55% |
| 2021-12-31 | CN¥9.07 Billion ≈ $1.33 Billion |
CN¥528.69 Million ≈ $77.36 Million |
0.058x | -67.22% |
| 2020-12-31 | CN¥8.92 Billion ≈ $1.31 Billion |
CN¥1.59 Billion ≈ $232.11 Million |
0.178x | +1950.92% |
| 2019-12-31 | CN¥7.95 Billion ≈ $1.16 Billion |
CN¥68.93 Million ≈ $10.09 Million |
0.009x | -9.41% |
| 2018-12-31 | CN¥7.56 Billion ≈ $1.11 Billion |
CN¥72.37 Million ≈ $10.59 Million |
0.010x | -40.65% |
| 2017-12-31 | CN¥7.11 Billion ≈ $1.04 Billion |
CN¥114.65 Million ≈ $16.78 Million |
0.016x | -86.60% |
| 2016-12-31 | CN¥5.33 Billion ≈ $780.36 Million |
CN¥641.45 Million ≈ $93.86 Million |
0.120x | +340.29% |
| 2015-12-31 | CN¥4.83 Billion ≈ $706.40 Million |
CN¥131.88 Million ≈ $19.30 Million |
0.027x | +13.93% |
| 2014-12-31 | CN¥4.42 Billion ≈ $646.31 Million |
CN¥105.90 Million ≈ $15.50 Million |
0.024x | +84.57% |
| 2013-12-31 | CN¥4.26 Billion ≈ $623.13 Million |
CN¥55.32 Million ≈ $8.10 Million |
0.013x | -28.77% |
| 2012-12-31 | CN¥3.84 Billion ≈ $562.64 Million |
CN¥70.13 Million ≈ $10.26 Million |
0.018x | +116.53% |
| 2011-12-31 | CN¥3.70 Billion ≈ $541.67 Million |
CN¥-408.49 Million ≈ $-59.77 Million |
-0.110x | -140.17% |
| 2010-12-31 | CN¥1.09 Billion ≈ $159.65 Million |
CN¥299.72 Million ≈ $43.86 Million |
0.275x | -31.75% |
| 2009-12-31 | CN¥790.55 Million ≈ $115.68 Million |
CN¥318.21 Million ≈ $46.56 Million |
0.403x | -7.30% |
| 2008-12-31 | CN¥484.03 Million ≈ $70.83 Million |
CN¥210.18 Million ≈ $30.76 Million |
0.434x | -- |
About Shijiazhuang Yiling Pharmaceutical Co Ltd
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine in China and internationally. It offers dietary supplements, and healthy food and drinks; patent TCM products for respiratory health, cardiovascular disease, diabetes, mellitus, oncology, urologic disease, sleep-improving, and anti-aging; disinfection and pers… Read more